Skip to main content
Clinical Trials/TCTR20230502003
TCTR20230502003Not yet recruitingPhase 3

Fluid bolus in suspected sepsis patients with hyperlactatemia: Open-labeled, Randomized controlled trial

Khon Kaen University0 sites224 target enrollmentStarted: May 2, 2023Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Enrollment
224

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to N/A (No limit) (—)
Sex
All

Inclusion Criteria

  • 1) Patients who suspected sepsis: SIRS criteria > or = 2 points + suspected or confirmed source of infection.
  • 2) Hyperlactatemia: Point-of-care serum lactate 2-4 mmol/L from arterial or venous blood gas.
  • 3) Ages over or equal 18 years old.

Exclusion Criteria

  • 1) Congestive heart failure or sign of volume overload or patient who had past history of low ejection fraction (%EF less than 40%) or Functional class IV
  • 2) ESRD with and without RRT
  • 3) Hypotension due to any cause (SBP < 90 mmHg or MAP < 65 mmHg)
  • 4) Morbid obesity (BMI > or = 40 kg/m2)
  • 5) Pregnancy
  • 6) Transferred from another hospital
  • 7) Administration of IV fluid before ED arrival
  • 8) Refused to participate or DNR
  • 9) Suspected type B lactic acidosis e.g., toxin-induced (metformin, isoniazid, NRTIs), liver failure or thiamine deficiency

Investigators

Similar Trials

Fluid bolus in suspected sepsis patients... | Clinical Trial